OPKO Health, Inc.
OPK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,020 | $1,135 | $899 | $3,117 |
| - Cash | $432 | $96 | $153 | $135 |
| + Debt | $504 | $327 | $306 | $188 |
| Enterprise Value | $1,093 | $1,366 | $1,051 | $3,170 |
| Revenue | $713 | $863 | $1,004 | $1,775 |
| % Growth | -17.4% | -14% | -43.4% | – |
| Gross Profit | $311 | $318 | $288 | $582 |
| % Margin | 43.6% | 36.8% | 28.7% | 32.8% |
| EBITDA | $135 | -$66 | -$271 | $84 |
| % Margin | 19% | -7.6% | -27% | 4.7% |
| Net Income | -$53 | -$189 | -$328 | -$30 |
| % Margin | -7.5% | -21.9% | -32.7% | -1.7% |
| EPS Diluted | -0.077 | -0.25 | -0.46 | -0.046 |
| % Growth | 69.3% | 45.7% | -911% | – |
| Operating Cash Flow | -$183 | -$28 | -$95 | $38 |
| Capital Expenditures | -$25 | -$16 | -$25 | -$32 |
| Free Cash Flow | -$208 | -$44 | -$120 | $6 |